1887
Surveillance Open Access
Like 0

Abstract

Background

Chickenpox, a vaccine-preventable disease caused by the varicella zoster virus, generally presents with mild symptoms but can cause complications necessitating hospitalisation. In Poland, since 2009, vaccination has been obligatory for children up to 12 years of age who are particularly vulnerable to infection and for children in their vicinity.

Aim

To examine the burden of chickenpox complications and the trends of hospitalisation arising from these complications over time in the Polish population.

Methods

Data spanning 2006–21 were sourced from the Polish Infectious Diseases Surveillance System, the Nationwide General Hospital Morbidity Study and the Statistics Poland death registry. Standardised and age-specific incidence rates, hospital discharge rates and number of deaths because of chickenpox were calculated. Moreover, the joinpoint regression model was used to analyse trends of annual hospital discharge rates.

Results

Over the analysed timeframe, 25,804 hospitalisations and 52 deaths attributable to chickenpox complications were documented, and 1.0% of chickenpox cases required hospitalisation because of chickenpox. Age-standardised hospitalisation rates varied between 2.3 and 9.6 per 100,000 population. The analysis revealed no statistically significant trend in overall hospital discharge rates from chickenpox complications. However, a notable increase in hospitalisation rates was observed in children aged 0–4 and among inhabitants of rural areas, with annual percentage changes of 4.9% and 3.4% respectively.

Conclusions

Our findings suggest that the implementation of a universal chickenpox immunisation programme, supported by health education, should be considered to reduce the number of hospitalisations and nearly eliminate deaths because of chickenpox.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.9.2300355
2024-02-29
2024-12-18
/content/10.2807/1560-7917.ES.2024.29.9.2300355
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/9/eurosurv-29-9-2.html?itemId=/content/10.2807/1560-7917.ES.2024.29.9.2300355&mimeType=html&fmt=ahah

References

  1. Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25(45):7866-72.  https://doi.org/10.1016/j.vaccine.2007.07.036  PMID: 17919788 
  2. Bernal JL, Hobbelen P, Amirthalingam G. Burden of varicella complications in secondary care, England, 2004 to 2017. Euro Surveill. 2019;24(42):1900233.  https://doi.org/10.2807/1560-7917.ES.2019.24.42.1900233  PMID: 31640840 
  3. Bonsignori F, Chiappini E, Frenos S, Peraldo M, Galli L, de Martino M. Hospitalization rates for complicated and uncomplicated chickenpox in a poorly vaccined pediatric population. Infection. 2007;35(6):444-50.  https://doi.org/10.1007/s15010-007-6248-z  PMID: 18034210 
  4. Głuchowska M, Paradowska-Stankiewicz I. Ospa wietrzna w Polsce w 2010 roku. [Chickenpox in Poland in 2010]. Przegl Epidemiol. 2012;66(2):205-9. Polish. PMID: 23101205 
  5. Varicella and herpes zoster vaccines: WHO position paper, June 2014--Recommendations. Vaccine. 2016;34(2):198-9.  https://doi.org/10.1016/j.vaccine.2014.07.068  PMID: 26723191 
  6. Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645-57.  https://doi.org/10.1080/21645515.2018.1546525  PMID: 30427766 
  7. Henry O, Brzostek J, Czajka H, Leviniene G, Reshetko O, Gasparini R, et al. One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life. Vaccine. 2018;36(3):381-7.  https://doi.org/10.1016/j.vaccine.2017.11.081  PMID: 29224964 
  8. Anderson R, Kim S, Roberts N, Petrou S. Systematic review of economic evaluations of varicella vaccination programmes. PLoS One. 2023;18(3):e0282327.  https://doi.org/10.1371/journal.pone.0282327  PMID: 36972249 
  9. Siennicka J, Trzcińska A, Rosińska M, Litwińska B. Seroprevalence of varicella-zoster virus in Polish population. Przegl Epidemiol. 2009;63(4):495-9. PMID: 20120946 
  10. Bogusz J, Ochocka P, Paradowska-Stankiewicz I. Chickenpox in Poland in 2019. Przegl Epidemiol. 2021;75(3):355-60.  https://doi.org/10.32394/pe.75.32  PMID: 35170291 
  11. Czarkowski M, Wielgosz U. Szczepienia ochronne w Polsce w 2022 roku. [Vaccination in Poland in 2022.] Warsaw: National Institute of Public Health - National Institute of Hygiene; 2023. Polish. Available from: https://wwwold.pzh.gov.pl/oldpage/epimeld/2022/Sz_2022.pdf
  12. Wysocki J, Malecka I, Stryczynska-Kazubska J, Rampakakis E, Kuter B, Wolfson LJ. Varicella in Poland: economic burden in children 1-12 years of age in Poland, 2010-2015. BMC Public Health.2018;18(1):410.  https://doi.org/10.1186/s12889-018-5298-8  PMID: 29587714 
  13. Ustawa z dnia 5 grudnia 2008 r. o zapobieganiu oraz zwalczaniu zakażeń i chorób zakaźnych u ludzi. [Act of 5 December 2008 on preventing and controlling infections and infectious diseases in humans]. Dz. U. 2008 Nr 234 poz. 1570. Internetowy System Aktów Prawnych; 5 Dec 2008. Polish. Available from: https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=wdu20082341570
  14. World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems (10th ed.).Version: 2016. Geneva: WHO. [Accessed: 6 Nov 2023]. Available from: https://icd.who.int/browse10/2016/en
  15. Poznańska A, Goryński P, Seroka W, Stokwiszewski J, Radomski P, Wojtyniak B. Nationwide General Hospital Morbidity Study as a source of data about Polish population health. Przegl Epidemiol. 2019;73(1):69-80.  https://doi.org/10.32394/pe.73.08  PMID: 31134776 
  16. Baza Demografia Główny Urząd Statystyczny. [Demographic Database of Statistics Poland]. 2024. Polish. Available from: https://demografia.stat.gov.pl/bazademografia
  17. Statistics Poland. Department of Epidemiology and Surveillance of Infectious Diseases. Definicje przypadków chorób zakaźnych na potrzeby nadzoru epidemiologicznego. [Definitions of infectious disease cases for epidemiological surveillance]. Ver. (6b). Warsaw: National Institute of Public Health - National Institute of Hygiene; 2020. Polish. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/inne/Def_PL2_6b.pdf
  18. Eurostat. Revision of the European Standard Population Report of Eurostat's task force. Luxembourg: Publications Office of the European Union; 2013. Available from: https://ec.europa.eu/eurostat/en/web/products-manuals-and-guidelines/-/ks-ra-13-028
  19. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-51.  https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z  PMID: 10649300 
  20. Rosińska M, Czarkowski MP, Sadkowska-Todys M. Infectious diseases in Poland in 2020. Przegl Epidemiol. 2022;76(4):514-27.  https://doi.org/10.32394/pe.76.47  PMID: 37017226 
  21. Bogusz J, Paradowska-Stankiewicz I. Chickenpox in Poland in 2020. Przegl Epidemiol. 2022;76(4):568-73.  https://doi.org/10.32394/pe.76.52  PMID: 37017449 
  22. Department of Epidemiology and Surveillance of Infectious Diseases. Choroby Zakaźne i Zatrucia w Polsce; 2008-2021. [Infectious Diseases and Poisonings in Poland; 2008-2021]. Warsaw: National Institute of Public Health – National Institute of Hygiene; 2022 Polish. Available from: https://wwwold.pzh.gov.pl/oldpage/epimeld/index_a.html
  23. European Centre for Disease Prevention and Control (ECDC). Varicella vaccination in the European Union. Stockholm: ECDC; 2015. Available from: https://op.europa.eu/en/publication-detail/-/publication/ccf10902-b7cb-43e8-81c3-719fe409dbdc/language-en/format-PDF
  24. Riera-Montes M, Bollaerts K, Heininger U, Hens N, Gabutti G, Gil A, et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017;17(1):353.  https://doi.org/10.1186/s12879-017-2445-2  PMID: 28521810 
  25. Huber A, Gazder J, Dobay O, Mészner Z, Horváth A. Attitudes towards varicella vaccination in parents and paediatric healthcare providers in Hungary. Vaccine. 2020;38(33):5249-55.  https://doi.org/10.1016/j.vaccine.2020.05.091  PMID: 32546413 
  26. Vezzosi L, Santagati G, Angelillo IF. Knowledge, attitudes, and behaviors of parents towards varicella and its vaccination. BMC Infect Dis. 2017;17(1):172.  https://doi.org/10.1186/s12879-017-2247-6  PMID: 28241788 
  27. Paradowska-Stankiewicz I, Pancer K, Poznańska A, Hordowicz M, Skibicka M, Słowiński M, et al. Tick-borne encephalitis epidemiology and surveillance in Poland, and comparison with selected European countries before and during the COVID-19 pandemic, 2008 to 2020. Euro Surveill. 2023;28(18):2200452.  https://doi.org/10.2807/1560-7917.ES.2023.28.18.2200452  PMID: 37140452 
  28. Berry JG, Gay JC, Joynt Maddox K, Coleman EA, Bucholz EM, O’Neill MR, et al. Age trends in 30 day hospital readmissions: US national retrospective analysis. BMJ. 2018;360:k497.  https://doi.org/10.1136/bmj.k497  PMID: 29487063 
/content/10.2807/1560-7917.ES.2024.29.9.2300355
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error